Cargando…

Novel hybridization- and tag-based error-corrected method for sensitive ctDNA mutation detection using ion semiconductor sequencing

Circulating tumor DNA (ctDNA) analysis has emerged as a clinically useful tool for cancer diagnostics and treatment monitoring. However, ctDNA detection is complicated by low DNA concentrations and technical challenges. Here we describe our newly developed sensitive method for ctDNA detection on the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tjensvoll, Kjersti, Lapin, Morten, Gilje, Bjørnar, Garresori, Herish, Oltedal, Satu, Forthun, Rakel Brendsdal, Molven, Anders, Rozenholc, Yves, Nordgård, Oddmund
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986848/ https://www.ncbi.nlm.nih.gov/pubmed/35388068 http://dx.doi.org/10.1038/s41598-022-09698-5

Ejemplares similares

Comprehensive ctDNA Measurements Improve Prediction of Clinical Outcomes and Enable Dynamic Tracking of Disease Progression in Advanced Pancreatic Cancer
por: Lapin, Morten, et al.
Publicado: (2023)

Monitoring of circulating tumour DNA in advanced pancreatic ductal adenocarcinoma predicts clinical outcome and reveals disease progression earlier than radiological imaging
por: Edland, Karin Hestnes, et al.
Publicado: (2023)

Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer
por: Lapin, Morten, et al.
Publicado: (2018)

Prognostic value of disseminated tumor cells in unresectable pancreatic ductal adenocarcinoma: a prospective observational study
por: Nordgård, Oddmund, et al.
Publicado: (2022)

MINDEC-An Enhanced Negative Depletion Strategy for Circulating Tumour Cell Enrichment
por: Lapin, Morten, et al.
Publicado: (2016)

Single-cell mRNA profiling reveals transcriptional heterogeneity among pancreatic circulating tumour cells
por: Lapin, Morten, et al.
Publicado: (2017)

Detection of disseminated tumor cells in bone marrow predict late recurrences in operable breast cancer patients
por: Tjensvoll, Kjersti, et al.
Publicado: (2019)

Liquid Biopsies in Solid Cancers: Implementation in a Nordic Healthcare System
por: Nordgård, Oddmund, et al.
Publicado: (2021)

Extracellular vesicles as a potential source of tumor-derived DNA in advanced pancreatic cancer
por: Lapin, Morten, et al.
Publicado: (2023)

Persistent tumor cells in bone marrow of non-metastatic breast cancer patients after primary surgery are associated with inferior outcome
por: Tjensvoll, Kjersti, et al.
Publicado: (2012)

Expression profiling and intracellular localization studies of the novel Proline-, Histidine-, and Glycine-rich protein 1 suggest an essential role in gastro-intestinal epithelium and a potential clinical application in colorectal cancer diagnostics
por: Oltedal, Satu, et al.
Publicado: (2018)

Comparison of molecular and immunocytochemical methods for detection of disseminated tumor cells in bone marrow from early breast cancer patients
por: Gilje, Bjørnar, et al.
Publicado: (2014)

The Prognostic Relevance of Sentinel Lymph Node Metastases Assessed by PHGR1 mRNA Quantification in Stage I to III Colon Cancer
por: Oltedal, Satu, et al.
Publicado: (2018)

ctDNA detected by ddPCR reveals changes in tumour load in metastatic malignant melanoma treated with bevacizumab
por: Forthun, Rakel Brendsdal, et al.
Publicado: (2019)

Mutation analysis by deep sequencing of pancreatic juice from patients with pancreatic ductal adenocarcinoma
por: Choi, Man Hung, et al.
Publicado: (2019)

Disease-stabilizing treatment based on all-trans retinoic acid and valproic acid in acute myeloid leukemia – identification of responders by gene expression profiling of pretreatment leukemic cells
por: Reikvam, Håkon, et al.
Publicado: (2017)

Treatment and Response Evaluation Challenges in a Pregnant Woman With B-Cell Lymphoblastic Leukemia and Li-Fraumeni Syndrome
por: Erikstein, Bjarte Skoe, et al.
Publicado: (2023)

Liquid biopsies and patient-reported outcome measures for integrative monitoring of patients with early-stage breast cancer: a study protocol for the longitudinal observational Prospective Breast Cancer Biobanking (PBCB) study
por: Søiland, Håvard, et al.
Publicado: (2022)

Cross-Species Functional Genomic Analysis Identifies Resistance Genes of the Histone Deacetylase Inhibitor Valproic Acid
por: Forthun, Rakel Brendsdal, et al.
Publicado: (2012)

Modulation of phospho-proteins by interferon-alpha and valproic acid in acute myeloid leukemia
por: Forthun, Rakel Brendsdal, et al.
Publicado: (2019)

High Constitutive Cytokine Release by Primary Human Acute Myeloid Leukemia Cells Is Associated with a Specific Intercellular Communication Phenotype
por: Reikvam, Håkon, et al.
Publicado: (2019)

Molecular Subtypes in Stage II-III Colon Cancer Defined by Genomic Instability: Early Recurrence-Risk Associated with a High Copy-Number Variation and Loss of RUNX3 and CDKN2A
por: Berg, Marianne, et al.
Publicado: (2015)

Selective inhibition of c-Myb DNA-binding by RNA polymers
por: Nordgård, Oddmund, et al.
Publicado: (2004)

Platelet Microparticles Decrease Daunorubicin-Induced DNA Damage and Modulate Intrinsic Apoptosis in THP-1 Cells
por: Cacic, Daniel, et al.
Publicado: (2021)

Platelet Microparticles Protect Acute Myelogenous Leukemia Cells against Daunorubicin-Induced Apoptosis
por: Cacic, Daniel, et al.
Publicado: (2021)

Global Cell Proteome Profiling, Phospho-signaling and Quantitative  Proteomics for Identification of New Biomarkers in Acute Myeloid  Leukemia Patients
por: Aasebø, Elise, et al.
Publicado: (2016)

Next-of-kin involvement in improving hospital cancer care quality and safety – a qualitative cross-case study as basis for theory development
por: Bergerød, Inger Johanne, et al.
Publicado: (2018)

Role of ctDNA in Breast Cancer
por: Sant, Marta, et al.
Publicado: (2022)

The Role of ctDNA in Gastric Cancer
por: Mencel, Justin, et al.
Publicado: (2022)

Utility of ctDNA Liquid Biopsies from Cancer Patients: An Institutional Study of 285 ctDNA Samples
por: Gumà, Josep, et al.
Publicado: (2022)

Treatment approach and survival from glioblastoma: results from a population-based retrospective cohort study from Western Norway
por: Bjorland, Line Sagerup, et al.
Publicado: (2021)

Developing a Next-of-Kin Involvement Guide in Cancer Care—Results From a Consensus Process
por: Bergerød, Inger J., et al.
Publicado: (2021)

The overriding role of surgery and tumor grade for long‐term survival in patients with gastroenteropancreatic neuroendocrine neoplasms: A population‐based cohort study
por: Søreide, Jon Arne, et al.
Publicado: (2021)

Assessment of clinically related outcomes and biomarker analysis for translational integration in colorectal cancer (ACROBATICC): study protocol for a population-based, consecutive cohort of surgically treated colorectal cancers and resected colorectal liver metastasis
por: Søreide, Kjetil, et al.
Publicado: (2016)

Clinical proteomics of myeloid leukemia
por: Hjelle, Sigrun M, et al.
Publicado: (2010)

Liquid Biopsy, ctDNA Diagnosis through NGS
por: Lin, Chen, et al.
Publicado: (2021)

ctDNA as a biomarker of progression in oesophageal adenocarcinoma
por: Bonazzi, V.F., et al.
Publicado: (2022)

State of the Art: ctDNA in Upper Gastrointestinal Malignancies
por: Labiano, Ibone, et al.
Publicado: (2023)

The circulating tumor DNA (ctDNA) alteration level predicts therapeutic response in metastatic breast cancer: Novel prognostic indexes based on ctDNA
por: Liu, Binliang, et al.
Publicado: (2022)

Potential value of ctDNA monitoring in metastatic HR + /HER2 − breast cancer: longitudinal ctDNA analysis in the phase Ib MONALEESASIA trial
por: Chiu, Joanne, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1lp09kksd7vh163l50p6g6a4ik